Rank | Gene Set | Z-score |
---|---|---|
1 | detection of bacterium (GO:0016045) | 7.68981249 |
2 | detection of other organism (GO:0098543) | 6.93038998 |
3 | leukocyte aggregation (GO:0070486) | 6.30698377 |
4 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.47251069 |
5 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.43094165 |
6 | defense response to fungus (GO:0050832) | 5.35642007 |
7 | desmosome organization (GO:0002934) | 5.30780692 |
8 | B cell receptor signaling pathway (GO:0050853) | 5.01680438 |
9 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.82518838 |
10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.52892940 |
11 | histone H3-K36 demethylation (GO:0070544) | 4.49796184 |
12 | gonadal mesoderm development (GO:0007506) | 4.43811012 |
13 | hemidesmosome assembly (GO:0031581) | 4.37918431 |
14 | neutrophil mediated immunity (GO:0002446) | 4.36215153 |
15 | detection of external biotic stimulus (GO:0098581) | 4.33089673 |
16 | regulation of water loss via skin (GO:0033561) | 4.31742017 |
17 | establishment of skin barrier (GO:0061436) | 4.30915464 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04189158 |
19 | neutrophil activation involved in immune response (GO:0002283) | 4.02687772 |
20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.99411300 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.95722238 |
22 | neutrophil activation (GO:0042119) | 3.92942891 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92874003 |
24 | cellular extravasation (GO:0045123) | 3.92122443 |
25 | sequestering of metal ion (GO:0051238) | 3.82910818 |
26 | regulation of podosome assembly (GO:0071801) | 3.79247043 |
27 | dendritic cell migration (GO:0036336) | 3.79024890 |
28 | B cell proliferation (GO:0042100) | 3.72661786 |
29 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.72608630 |
30 | dendritic cell chemotaxis (GO:0002407) | 3.72350279 |
31 | positive regulation of mast cell activation (GO:0033005) | 3.68366230 |
32 | detection of biotic stimulus (GO:0009595) | 3.62869573 |
33 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.58662875 |
34 | granulocyte activation (GO:0036230) | 3.54626985 |
35 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.54452833 |
36 | vitamin transmembrane transport (GO:0035461) | 3.50441576 |
37 | superoxide anion generation (GO:0042554) | 3.48032802 |
38 | multicellular organismal water homeostasis (GO:0050891) | 3.48022162 |
39 | response to type I interferon (GO:0034340) | 3.45439584 |
40 | type I interferon signaling pathway (GO:0060337) | 3.45237686 |
41 | cellular response to type I interferon (GO:0071357) | 3.45237686 |
42 | response to fungus (GO:0009620) | 3.44837539 |
43 | surfactant homeostasis (GO:0043129) | 3.42919484 |
44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39855224 |
45 | positive regulation of mast cell degranulation (GO:0043306) | 3.39855224 |
46 | chronic inflammatory response (GO:0002544) | 3.39576042 |
47 | regulation of guanylate cyclase activity (GO:0031282) | 3.33271100 |
48 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.32055003 |
49 | leukotriene metabolic process (GO:0006691) | 3.30893388 |
50 | adhesion of symbiont to host cell (GO:0044650) | 3.30489863 |
51 | virion attachment to host cell (GO:0019062) | 3.30489863 |
52 | immunoglobulin mediated immune response (GO:0016064) | 3.26561255 |
53 | B cell homeostasis (GO:0001782) | 3.24917499 |
54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.24705138 |
55 | keratinocyte differentiation (GO:0030216) | 3.23998699 |
56 | intestinal epithelial cell development (GO:0060576) | 3.23752009 |
57 | myeloid leukocyte mediated immunity (GO:0002444) | 3.22642739 |
58 | actin filament depolymerization (GO:0030042) | 3.22509874 |
59 | positive thymic T cell selection (GO:0045059) | 3.19220350 |
60 | diterpenoid biosynthetic process (GO:0016102) | 3.18681334 |
61 | regulation of natural killer cell differentiation (GO:0032823) | 3.18222457 |
62 | thymic T cell selection (GO:0045061) | 3.17342009 |
63 | chemical homeostasis within a tissue (GO:0048875) | 3.16121059 |
64 | positive regulation of p38MAPK cascade (GO:1900745) | 3.15408856 |
65 | sulfate transmembrane transport (GO:1902358) | 3.11257633 |
66 | positive regulation of protein oligomerization (GO:0032461) | 3.09990203 |
67 | cytidine deamination (GO:0009972) | 3.09924682 |
68 | cytidine metabolic process (GO:0046087) | 3.09924682 |
69 | cytidine catabolic process (GO:0006216) | 3.09924682 |
70 | positive regulation of protein homooligomerization (GO:0032464) | 3.08969159 |
71 | regulation of bile acid biosynthetic process (GO:0070857) | 3.07718519 |
72 | regulation of mast cell degranulation (GO:0043304) | 3.04883894 |
73 | exogenous drug catabolic process (GO:0042738) | 3.03236688 |
74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02942816 |
75 | positive regulation of interferon-alpha production (GO:0032727) | 3.02629176 |
76 | angiotensin maturation (GO:0002003) | 3.01513847 |
77 | respiratory burst (GO:0045730) | 3.01155650 |
78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99873989 |
79 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99337958 |
80 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.98844000 |
81 | lipoxygenase pathway (GO:0019372) | 2.98337127 |
82 | T cell lineage commitment (GO:0002360) | 2.97493625 |
83 | intestinal absorption (GO:0050892) | 2.97263389 |
84 | regulation of antigen processing and presentation (GO:0002577) | 2.94572854 |
85 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.91752552 |
86 | B cell mediated immunity (GO:0019724) | 2.91017942 |
87 | regulation of cholesterol homeostasis (GO:2000188) | 2.90942212 |
88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90271425 |
89 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.88906589 |
90 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.88906589 |
91 | regulation of interferon-alpha production (GO:0032647) | 2.88568106 |
92 | hepatocyte differentiation (GO:0070365) | 2.87339109 |
93 | cellular response to exogenous dsRNA (GO:0071360) | 2.87169653 |
94 | mRNA modification (GO:0016556) | 2.86997526 |
95 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85721842 |
96 | NADH metabolic process (GO:0006734) | 2.85336607 |
97 | leukotriene biosynthetic process (GO:0019370) | 2.84899354 |
98 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.84398090 |
99 | NIK/NF-kappaB signaling (GO:0038061) | 2.84241187 |
100 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84094819 |
101 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.82557212 |
102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.82275367 |
103 | keratinization (GO:0031424) | 2.80797034 |
104 | regulation of leukocyte degranulation (GO:0043300) | 2.78548077 |
105 | defense response to protozoan (GO:0042832) | 2.77836294 |
106 | ectoderm development (GO:0007398) | 2.77510582 |
107 | germinal center formation (GO:0002467) | 2.77153725 |
108 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.75182690 |
109 | intestinal cholesterol absorption (GO:0030299) | 2.75181337 |
110 | regulation of mast cell activation (GO:0033003) | 2.74370550 |
111 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.73760064 |
112 | wound healing, spreading of epidermal cells (GO:0035313) | 2.73380986 |
113 | water homeostasis (GO:0030104) | 2.72637671 |
114 | drug catabolic process (GO:0042737) | 2.72376996 |
115 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.72103162 |
116 | epoxygenase P450 pathway (GO:0019373) | 2.71861134 |
117 | T cell selection (GO:0045058) | 2.70951594 |
118 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.69717102 |
119 | hepatocyte apoptotic process (GO:0097284) | 2.69378082 |
120 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.66273053 |
121 | regulation of interleukin-8 secretion (GO:2000482) | 2.65919416 |
122 | cellular glucuronidation (GO:0052695) | 2.65730884 |
123 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.64568602 |
124 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64088729 |
125 | sulfate transport (GO:0008272) | 2.62948223 |
126 | daunorubicin metabolic process (GO:0044597) | 2.62787718 |
127 | polyketide metabolic process (GO:0030638) | 2.62787718 |
128 | doxorubicin metabolic process (GO:0044598) | 2.62787718 |
129 | innate immune response in mucosa (GO:0002227) | 2.60285799 |
130 | interferon-gamma secretion (GO:0072643) | 2.60156613 |
131 | growth hormone receptor signaling pathway (GO:0060396) | 2.57986419 |
132 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57915263 |
133 | negative thymic T cell selection (GO:0045060) | 2.57046389 |
134 | regulation of p38MAPK cascade (GO:1900744) | 2.56622315 |
135 | response to host (GO:0075136) | 2.56569492 |
136 | response to host defenses (GO:0052200) | 2.56569492 |
137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56569492 |
138 | regulation of B cell differentiation (GO:0045577) | 2.55915470 |
139 | disruption of cells of other organism (GO:0044364) | 2.55472559 |
140 | killing of cells of other organism (GO:0031640) | 2.55472559 |
141 | defense response to Gram-positive bacterium (GO:0050830) | 2.54346517 |
142 | establishment of endothelial barrier (GO:0061028) | 2.52751346 |
143 | morphogenesis of an endothelium (GO:0003159) | 2.51617511 |
144 | endothelial tube morphogenesis (GO:0061154) | 2.51617511 |
145 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51348984 |
146 | T cell migration (GO:0072678) | 2.50704989 |
147 | adhesion of symbiont to host (GO:0044406) | 2.50538171 |
148 | glucuronate metabolic process (GO:0019585) | 2.50343274 |
149 | uronic acid metabolic process (GO:0006063) | 2.50343274 |
150 | phagosome maturation (GO:0090382) | 2.49385381 |
151 | negative regulation of mast cell activation (GO:0033004) | 2.49261233 |
152 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.48098972 |
153 | response to host immune response (GO:0052572) | 2.48081288 |
154 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48081288 |
155 | regulation of regulated secretory pathway (GO:1903305) | 2.47597063 |
156 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47090531 |
157 | positive regulation of regulated secretory pathway (GO:1903307) | 2.46731360 |
158 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.46416790 |
159 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.46416790 |
160 | regulation of B cell proliferation (GO:0030888) | 2.46307878 |
161 | epidermal cell differentiation (GO:0009913) | 2.43855975 |
162 | tachykinin receptor signaling pathway (GO:0007217) | 2.42900005 |
163 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.42787975 |
164 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.42787975 |
165 | positive regulation of antigen processing and presentation (GO:0002579) | 2.42198061 |
166 | negative regulation of cell killing (GO:0031342) | 2.42000238 |
167 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.42000238 |
168 | neutrophil chemotaxis (GO:0030593) | 2.40937605 |
169 | hypotonic response (GO:0006971) | 2.40340587 |
170 | phospholipid efflux (GO:0033700) | 2.39850535 |
171 | vitamin A metabolic process (GO:0006776) | 2.38855156 |
172 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38393128 |
173 | response to protozoan (GO:0001562) | 2.38121229 |
174 | drug metabolic process (GO:0017144) | 2.37945893 |
175 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.36682246 |
176 | negative T cell selection (GO:0043383) | 2.36242887 |
177 | positive T cell selection (GO:0043368) | 2.36140017 |
178 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.35192595 |
179 | rRNA catabolic process (GO:0016075) | 2.35095068 |
180 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.34567058 |
181 | positive regulation of B cell proliferation (GO:0030890) | 2.34066991 |
182 | cellular response to virus (GO:0098586) | 2.32309817 |
183 | lipoprotein transport (GO:0042953) | 2.30752121 |
184 | peptide catabolic process (GO:0043171) | 2.30117184 |
185 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.26992707 |
186 | transcription from mitochondrial promoter (GO:0006390) | 2.26919618 |
187 | basic amino acid transport (GO:0015802) | 2.26549433 |
188 | negative regulation of histone methylation (GO:0031061) | 2.26386211 |
189 | drug transmembrane transport (GO:0006855) | 2.26117629 |
190 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.24155115 |
191 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.23511855 |
192 | regulation of interferon-beta production (GO:0032648) | 2.23463244 |
193 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.21863305 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.88414529 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69020805 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.75399626 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.67275181 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91445432 |
6 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.89504339 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.88767749 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85008364 |
9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.81437920 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.75352490 |
11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.45286330 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39068190 |
13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.24081476 |
14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.12375421 |
15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.11992028 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10676435 |
17 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.04874625 |
18 | MYB_26560356_Chip-Seq_TH2_Human | 2.04475906 |
19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.97554155 |
20 | MYB_26560356_Chip-Seq_TH1_Human | 1.94100163 |
21 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.93657056 |
22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87752233 |
23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76314289 |
24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75845165 |
25 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.73632397 |
26 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71610850 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70160451 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69745399 |
29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68921791 |
30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65630428 |
31 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.65426772 |
32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65362312 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64971479 |
34 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.64770950 |
35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.64629975 |
36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63918367 |
37 | RXR_22108803_ChIP-Seq_LS180_Human | 1.58993205 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.56888283 |
39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56507957 |
40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55807647 |
41 | MAF_26560356_Chip-Seq_TH1_Human | 1.55207944 |
42 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.53163088 |
43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53069379 |
44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52605092 |
45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52417637 |
46 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48929886 |
47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48533083 |
48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.47398458 |
49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46553108 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46060661 |
51 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44591724 |
52 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39880920 |
53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39359553 |
54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38882217 |
55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38641078 |
56 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38531351 |
57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38214059 |
58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36254819 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35971640 |
60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35520185 |
61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35072112 |
62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34964833 |
63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.34651185 |
64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.34342071 |
65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33688220 |
66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33510204 |
67 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.32990401 |
68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31956531 |
69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31956531 |
70 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.31923608 |
71 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31831613 |
72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26172007 |
73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24304843 |
74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22805838 |
75 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22755102 |
76 | P300_27268052_Chip-Seq_Bcells_Human | 1.22164725 |
77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20688455 |
78 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16284291 |
79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14598573 |
80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14585108 |
81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13720104 |
82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.12632440 |
83 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12332767 |
84 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11081357 |
85 | MAF_26560356_Chip-Seq_TH2_Human | 1.08103452 |
86 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07282146 |
87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06423178 |
88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05887940 |
89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04059825 |
90 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03982385 |
91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03812656 |
92 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03786140 |
93 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03343656 |
94 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03321999 |
95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02874318 |
96 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.01336287 |
97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01065883 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00682775 |
99 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.99810783 |
100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99560154 |
101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98523587 |
102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98001254 |
103 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97997590 |
104 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97761444 |
105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.97316281 |
106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97177420 |
107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97111436 |
108 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96461305 |
109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95535093 |
110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95496916 |
111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95321624 |
112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94697696 |
113 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93653297 |
114 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93422517 |
115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93028241 |
116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92786448 |
117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92526987 |
118 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.91844656 |
119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91818925 |
120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91126425 |
121 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90765413 |
122 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.90694580 |
123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90114271 |
124 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89932743 |
125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89821786 |
126 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89523121 |
127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89169152 |
128 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89140990 |
129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88702888 |
130 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88511940 |
131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88363321 |
132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88133514 |
133 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.88039216 |
134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87950360 |
135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86743324 |
136 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86713452 |
137 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.85933691 |
138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85675411 |
139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85515287 |
140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85446519 |
141 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84875904 |
142 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.84275522 |
143 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84033087 |
144 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83810618 |
145 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.83624236 |
146 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83600414 |
147 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83515417 |
148 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83324538 |
149 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.82694928 |
150 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82595335 |
151 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.82466344 |
152 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82465421 |
153 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82285854 |
154 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.81988325 |
155 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81557974 |
156 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.81054878 |
157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80192089 |
158 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.80059991 |
159 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79353779 |
160 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79174586 |
161 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.77270864 |
162 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.77270864 |
163 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.77270864 |
164 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75647302 |
165 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.74742471 |
166 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73336811 |
167 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71933181 |
168 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.71743530 |
169 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71052870 |
170 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.71039587 |
171 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.70081030 |
172 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.68809909 |
173 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.68388074 |
174 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67874646 |
175 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.67618073 |
176 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67241677 |
177 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.67144186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 3.98113572 |
2 | MP0003183_abnormal_peptide_metabolism | 3.98001954 |
3 | MP0002277_abnormal_respiratory_mucosa | 3.97075374 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.92316697 |
5 | MP0002796_impaired_skin_barrier | 3.50781849 |
6 | MP0005360_urolithiasis | 3.39199044 |
7 | MP0002138_abnormal_hepatobiliary_system | 3.36481135 |
8 | MP0009278_abnormal_bone_marrow | 3.18115070 |
9 | MP0003453_abnormal_keratinocyte_physiol | 3.05324965 |
10 | MP0000566_synostosis | 2.98821566 |
11 | MP0003941_abnormal_skin_development | 2.77591547 |
12 | MP0001835_abnormal_antigen_presentation | 2.75701448 |
13 | MP0004264_abnormal_extraembryonic_tissu | 2.73346755 |
14 | MP0008004_abnormal_stomach_pH | 2.71446655 |
15 | MP0003195_calcinosis | 2.63843461 |
16 | MP0004782_abnormal_surfactant_physiolog | 2.45299912 |
17 | MP0010678_abnormal_skin_adnexa | 2.44654207 |
18 | MP0005085_abnormal_gallbladder_physiolo | 2.44025643 |
19 | MP0002098_abnormal_vibrissa_morphology | 2.36400330 |
20 | MP0005501_abnormal_skin_physiology | 2.32463387 |
21 | MP0002254_reproductive_system_inflammat | 2.25999551 |
22 | MP0005671_abnormal_response_to | 2.21132492 |
23 | MP0000383_abnormal_hair_follicle | 2.19546451 |
24 | MP0003136_yellow_coat_color | 2.14849835 |
25 | MP0001216_abnormal_epidermal_layer | 2.14743212 |
26 | MP0001346_abnormal_lacrimal_gland | 2.13966882 |
27 | MP0005365_abnormal_bile_salt | 2.08436833 |
28 | MP0003693_abnormal_embryo_hatching | 2.06764099 |
29 | MP0009785_altered_susceptibility_to | 2.05218571 |
30 | MP0008057_abnormal_DNA_replication | 2.02250689 |
31 | MP0003436_decreased_susceptibility_to | 2.01090424 |
32 | MP0002060_abnormal_skin_morphology | 1.96099046 |
33 | MP0003566_abnormal_cell_adhesion | 1.95281299 |
34 | MP0003763_abnormal_thymus_physiology | 1.91275083 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.91272637 |
36 | MP0003646_muscle_fatigue | 1.86729709 |
37 | MP0002723_abnormal_immune_serum | 1.86107154 |
38 | MP0004381_abnormal_hair_follicle | 1.83770299 |
39 | MP0000427_abnormal_hair_cycle | 1.76922319 |
40 | MP0009840_abnormal_foam_cell | 1.75816522 |
41 | MP0001666_abnormal_nutrient_absorption | 1.70295419 |
42 | MP0002653_abnormal_ependyma_morphology | 1.66505506 |
43 | MP0002166_altered_tumor_susceptibility | 1.66473135 |
44 | MP0002837_dystrophic_cardiac_calcinosis | 1.64847398 |
45 | MP0004947_skin_inflammation | 1.64453842 |
46 | MP0003252_abnormal_bile_duct | 1.60695140 |
47 | MP0010771_integument_phenotype | 1.60642290 |
48 | MP0002132_abnormal_respiratory_system | 1.60446654 |
49 | MP0002163_abnormal_gland_morphology | 1.57198038 |
50 | MP0000579_abnormal_nail_morphology | 1.53431996 |
51 | MP0001664_abnormal_digestion | 1.53338947 |
52 | MP0001873_stomach_inflammation | 1.51970484 |
53 | MP0000716_abnormal_immune_system | 1.43099419 |
54 | MP0010352_gastrointestinal_tract_polyps | 1.41551669 |
55 | MP0003724_increased_susceptibility_to | 1.40264155 |
56 | MP0005310_abnormal_salivary_gland | 1.39097449 |
57 | MP0000689_abnormal_spleen_morphology | 1.39003277 |
58 | MP0005332_abnormal_amino_acid | 1.38660556 |
59 | MP0000516_abnormal_urinary_system | 1.38321642 |
60 | MP0005367_renal/urinary_system_phenotyp | 1.38321642 |
61 | MP0002398_abnormal_bone_marrow | 1.37728080 |
62 | MP0005248_abnormal_Harderian_gland | 1.36315962 |
63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35570842 |
64 | MP0000762_abnormal_tongue_morphology | 1.33423688 |
65 | MP0005377_hearing/vestibular/ear_phenot | 1.32962206 |
66 | MP0003878_abnormal_ear_physiology | 1.32962206 |
67 | MP0002419_abnormal_innate_immunity | 1.32935217 |
68 | MP0005171_absent_coat_pigmentation | 1.32589418 |
69 | MP0003806_abnormal_nucleotide_metabolis | 1.31743302 |
70 | MP0003950_abnormal_plasma_membrane | 1.30642739 |
71 | MP0010094_abnormal_chromosome_stability | 1.30383466 |
72 | MP0002006_tumorigenesis | 1.29682764 |
73 | MP0005387_immune_system_phenotype | 1.23920627 |
74 | MP0001790_abnormal_immune_system | 1.23920627 |
75 | MP0010329_abnormal_lipoprotein_level | 1.21731327 |
76 | MP0003111_abnormal_nucleus_morphology | 1.21288914 |
77 | MP0005167_abnormal_blood-brain_barrier | 1.20197867 |
78 | MP0005451_abnormal_body_composition | 1.20026653 |
79 | MP0005275_abnormal_skin_tensile | 1.19964653 |
80 | MP0001764_abnormal_homeostasis | 1.19878871 |
81 | MP0009764_decreased_sensitivity_to | 1.18676454 |
82 | MP0004043_abnormal_pH_regulation | 1.16531818 |
83 | MP0002429_abnormal_blood_cell | 1.16460305 |
84 | MP0000467_abnormal_esophagus_morphology | 1.14781340 |
85 | MP0002148_abnormal_hypersensitivity_rea | 1.11885294 |
86 | MP0008789_abnormal_olfactory_epithelium | 1.11418225 |
87 | MP0000685_abnormal_immune_system | 1.11341089 |
88 | MP0000470_abnormal_stomach_morphology | 1.11117693 |
89 | MP0004957_abnormal_blastocyst_morpholog | 1.10691696 |
90 | MP0005379_endocrine/exocrine_gland_phen | 1.09171348 |
91 | MP0005025_abnormal_response_to | 1.08920224 |
92 | MP0000609_abnormal_liver_physiology | 1.08102290 |
93 | MP0001191_abnormal_skin_condition | 1.06864968 |
94 | MP0002722_abnormal_immune_system | 1.06845853 |
95 | MP0010155_abnormal_intestine_physiology | 1.06627896 |
96 | MP0002396_abnormal_hematopoietic_system | 1.06326952 |
97 | MP0000490_abnormal_crypts_of | 1.04585915 |
98 | MP0009643_abnormal_urine_homeostasis | 1.04555620 |
99 | MP0005164_abnormal_response_to | 1.04075806 |
100 | MP0003303_peritoneal_inflammation | 1.03435510 |
101 | MP0004019_abnormal_vitamin_homeostasis | 1.03364552 |
102 | MP0001533_abnormal_skeleton_physiology | 1.03256775 |
103 | MP0000678_abnormal_parathyroid_gland | 1.02281171 |
104 | MP0000377_abnormal_hair_follicle | 1.00221444 |
105 | MP0002009_preneoplasia | 0.99462395 |
106 | MP0002136_abnormal_kidney_physiology | 0.98893235 |
107 | MP0000462_abnormal_digestive_system | 0.97452109 |
108 | MP0004883_abnormal_blood_vessel | 0.96634601 |
109 | MP0001661_extended_life_span | 0.96343929 |
110 | MP0002876_abnormal_thyroid_physiology | 0.95996340 |
111 | MP0001881_abnormal_mammary_gland | 0.94551111 |
112 | MP0000465_gastrointestinal_hemorrhage | 0.94297402 |
113 | MP0003879_abnormal_hair_cell | 0.93995042 |
114 | MP0003866_abnormal_defecation | 0.93919256 |
115 | MP0009931_abnormal_skin_appearance | 0.93602717 |
116 | MP0002693_abnormal_pancreas_physiology | 0.93480675 |
117 | MP0008469_abnormal_protein_level | 0.92175920 |
118 | MP0002933_joint_inflammation | 0.92050069 |
119 | MP0001663_abnormal_digestive_system | 0.90510969 |
120 | MP0002452_abnormal_antigen_presenting | 0.90169651 |
121 | MP0002405_respiratory_system_inflammati | 0.88654700 |
122 | MP0001853_heart_inflammation | 0.88556269 |
123 | MP0003300_gastrointestinal_ulcer | 0.84880974 |
124 | MP0003077_abnormal_cell_cycle | 0.84879787 |
125 | MP0005381_digestive/alimentary_phenotyp | 0.84803659 |
126 | MP0001800_abnormal_humoral_immune | 0.84733894 |
127 | MP0001819_abnormal_immune_cell | 0.83752625 |
128 | MP0002420_abnormal_adaptive_immunity | 0.81347138 |
129 | MP0000703_abnormal_thymus_morphology | 0.81174940 |
130 | MP0000858_altered_metastatic_potential | 0.81159427 |
131 | MP0001958_emphysema | 0.81131313 |
132 | MP0005645_abnormal_hypothalamus_physiol | 0.80501939 |
133 | MP0005166_decreased_susceptibility_to | 0.80023061 |
134 | MP0001845_abnormal_inflammatory_respons | 0.79665096 |
135 | MP0005084_abnormal_gallbladder_morpholo | 0.79112186 |
136 | MP0001485_abnormal_pinna_reflex | 0.78902836 |
137 | MP0005397_hematopoietic_system_phenotyp | 0.78622622 |
138 | MP0001545_abnormal_hematopoietic_system | 0.78622622 |
139 | MP0001765_abnormal_ion_homeostasis | 0.77187667 |
140 | MP0000627_abnormal_mammary_gland | 0.76709165 |
141 | MP0003075_altered_response_to | 0.76242070 |
142 | MP0001984_abnormal_olfaction | 0.75894591 |
143 | MP0005023_abnormal_wound_healing | 0.74076818 |
144 | MP0001986_abnormal_taste_sensitivity | 0.73655249 |
145 | MP0003786_premature_aging | 0.73452010 |
146 | MP0006292_abnormal_olfactory_placode | 0.73144716 |
147 | MP0000477_abnormal_intestine_morphology | 0.72823561 |
148 | MP0005499_abnormal_olfactory_system | 0.72554465 |
149 | MP0005394_taste/olfaction_phenotype | 0.72554465 |
150 | MP0001730_embryonic_growth_arrest | 0.70306194 |
151 | MP0006035_abnormal_mitochondrial_morpho | 0.69548377 |
152 | MP0003191_abnormal_cellular_cholesterol | 0.69242553 |
153 | MP0005000_abnormal_immune_tolerance | 0.69216163 |
154 | MP0002019_abnormal_tumor_incidence | 0.67775402 |
155 | MP0003172_abnormal_lysosome_physiology | 0.65117893 |
156 | MP0002118_abnormal_lipid_homeostasis | 0.64555054 |
157 | MP0008877_abnormal_DNA_methylation | 0.64396685 |
158 | MP0005075_abnormal_melanosome_morpholog | 0.63815595 |
159 | MP0003045_fibrosis | 0.61875536 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 5.82873193 |
2 | Eczematoid dermatitis (HP:0000976) | 5.28566957 |
3 | Onycholysis (HP:0001806) | 4.74338058 |
4 | Spontaneous hematomas (HP:0007420) | 4.64825659 |
5 | Agammaglobulinemia (HP:0004432) | 4.63220481 |
6 | Recurrent abscess formation (HP:0002722) | 3.96558523 |
7 | Parakeratosis (HP:0001036) | 3.94153259 |
8 | Plantar hyperkeratosis (HP:0007556) | 3.90871354 |
9 | Gastrointestinal stroma tumor (HP:0100723) | 3.69289957 |
10 | Pustule (HP:0200039) | 3.58216597 |
11 | Recurrent sinusitis (HP:0011108) | 3.57810169 |
12 | Lip pit (HP:0100267) | 3.56893100 |
13 | Milia (HP:0001056) | 3.50140531 |
14 | IgM deficiency (HP:0002850) | 3.45242415 |
15 | Recurrent bacterial skin infections (HP:0005406) | 3.42585939 |
16 | Increased IgE level (HP:0003212) | 3.35552231 |
17 | Colitis (HP:0002583) | 3.30286810 |
18 | Aplasia cutis congenita (HP:0001057) | 3.28714285 |
19 | Chronic diarrhea (HP:0002028) | 3.21378431 |
20 | Corneal erosion (HP:0200020) | 3.11495151 |
21 | Hematochezia (HP:0002573) | 3.09982254 |
22 | Recurrent corneal erosions (HP:0000495) | 3.07838158 |
23 | Cheilitis (HP:0100825) | 3.05020663 |
24 | Dehydration (HP:0001944) | 3.01876105 |
25 | Palmar hyperkeratosis (HP:0010765) | 3.01838182 |
26 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.00413000 |
27 | Hyperactive renin-angiotensin system (HP:0000841) | 3.00323443 |
28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.96849222 |
29 | Chronic bronchitis (HP:0004469) | 2.96723450 |
30 | Ectropion (HP:0000656) | 2.95390170 |
31 | Palmoplantar hyperkeratosis (HP:0000972) | 2.92077139 |
32 | Gingivitis (HP:0000230) | 2.89258757 |
33 | Ventricular tachycardia (HP:0004756) | 2.88524791 |
34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83630183 |
35 | Curly hair (HP:0002212) | 2.83583288 |
36 | Urticaria (HP:0001025) | 2.82876984 |
37 | Recurrent viral infections (HP:0004429) | 2.81193436 |
38 | Panhypogammaglobulinemia (HP:0003139) | 2.79692020 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.79224906 |
40 | Obstructive lung disease (HP:0006536) | 2.77330932 |
41 | Chronic obstructive pulmonary disease (HP:0006510) | 2.77330932 |
42 | Recurrent bronchitis (HP:0002837) | 2.71624004 |
43 | Papilloma (HP:0012740) | 2.68793852 |
44 | Verrucae (HP:0200043) | 2.68793852 |
45 | Fragile nails (HP:0001808) | 2.68751688 |
46 | Lymphopenia (HP:0001888) | 2.67804089 |
47 | Abnormality of macrophages (HP:0004311) | 2.63139472 |
48 | Gastrointestinal inflammation (HP:0004386) | 2.62725870 |
49 | Absent eyebrow (HP:0002223) | 2.62046494 |
50 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.61905653 |
51 | IgA deficiency (HP:0002720) | 2.61735014 |
52 | Vasculitis (HP:0002633) | 2.59950429 |
53 | Alopecia of scalp (HP:0002293) | 2.58373109 |
54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57299564 |
55 | Atrophic scars (HP:0001075) | 2.56183670 |
56 | Abnormality of chloride homeostasis (HP:0011422) | 2.55866664 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.54100549 |
58 | Malnutrition (HP:0004395) | 2.53853621 |
59 | Hyperglycinuria (HP:0003108) | 2.53824919 |
60 | Decreased circulating renin level (HP:0003351) | 2.53346291 |
61 | Pili torti (HP:0003777) | 2.51114946 |
62 | Woolly hair (HP:0002224) | 2.48449814 |
63 | Hypobetalipoproteinemia (HP:0003563) | 2.44391016 |
64 | Autoimmune thrombocytopenia (HP:0001973) | 2.43991360 |
65 | Sepsis (HP:0100806) | 2.42659578 |
66 | Hypoplasia of dental enamel (HP:0006297) | 2.39535328 |
67 | Amelogenesis imperfecta (HP:0000705) | 2.37935842 |
68 | Recurrent fungal infections (HP:0002841) | 2.32820462 |
69 | Hypotrichosis (HP:0001006) | 2.30379552 |
70 | Hypoplastic labia majora (HP:0000059) | 2.29469579 |
71 | Hypohidrosis (HP:0000966) | 2.28319749 |
72 | Portal hypertension (HP:0001409) | 2.27646531 |
73 | Premature loss of primary teeth (HP:0006323) | 2.27549835 |
74 | Viral hepatitis (HP:0006562) | 2.27003256 |
75 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.24669705 |
76 | Villous atrophy (HP:0011473) | 2.24669705 |
77 | Bronchitis (HP:0012387) | 2.23354530 |
78 | Absent/shortened dynein arms (HP:0200106) | 2.22994082 |
79 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.22994082 |
80 | Homocystinuria (HP:0002156) | 2.22892692 |
81 | Abnormality of homocysteine metabolism (HP:0010919) | 2.22892692 |
82 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.22444122 |
83 | Hyperphosphatemia (HP:0002905) | 2.21530895 |
84 | Abnormality of the hepatic vasculature (HP:0006707) | 2.21426593 |
85 | Mediastinal lymphadenopathy (HP:0100721) | 2.21026734 |
86 | Gastrointestinal infarctions (HP:0005244) | 2.17843138 |
87 | Chronic otitis media (HP:0000389) | 2.17226470 |
88 | Nail dystrophy (HP:0008404) | 2.16277090 |
89 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14849516 |
90 | IgG deficiency (HP:0004315) | 2.12604919 |
91 | Recurrent pneumonia (HP:0006532) | 2.10113777 |
92 | Emphysema (HP:0002097) | 2.09260352 |
93 | Vascular calcification (HP:0004934) | 2.08567472 |
94 | Symptomatic seizures (HP:0011145) | 2.08238492 |
95 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.08125047 |
96 | Abnormality of the gastric mucosa (HP:0004295) | 2.07448036 |
97 | Abnormality of proline metabolism (HP:0010907) | 2.05904658 |
98 | Hydroxyprolinuria (HP:0003080) | 2.05904658 |
99 | Progressive sensorineural hearing impairment (HP:0000408) | 2.05563155 |
100 | Generalized aminoaciduria (HP:0002909) | 2.04477696 |
101 | Cellulitis (HP:0100658) | 2.04431754 |
102 | Abnormality of T cells (HP:0002843) | 2.03847323 |
103 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03591750 |
104 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03591750 |
105 | Abnormality of vitamin B metabolism (HP:0004340) | 2.03247430 |
106 | Late onset (HP:0003584) | 2.02493131 |
107 | Abnormality of glycine metabolism (HP:0010895) | 1.99606114 |
108 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99606114 |
109 | Hyponatremia (HP:0002902) | 1.98683356 |
110 | Abnormality of the prostate (HP:0008775) | 1.97746077 |
111 | Septate vagina (HP:0001153) | 1.96171576 |
112 | Abnormality of the labia majora (HP:0012881) | 1.95118758 |
113 | Erythroderma (HP:0001019) | 1.94434066 |
114 | Blepharitis (HP:0000498) | 1.93529012 |
115 | Abnormal blistering of the skin (HP:0008066) | 1.93253517 |
116 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.92507266 |
117 | Widely patent fontanelles and sutures (HP:0004492) | 1.91712342 |
118 | Short femoral neck (HP:0100864) | 1.90817974 |
119 | Skin ulcer (HP:0200042) | 1.90303951 |
120 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.89967007 |
121 | Abnormal biliary tract physiology (HP:0012439) | 1.89053102 |
122 | Bile duct proliferation (HP:0001408) | 1.89053102 |
123 | Recurrent skin infections (HP:0001581) | 1.88858592 |
124 | Inflammation of the large intestine (HP:0002037) | 1.88400540 |
125 | Progressive hearing impairment (HP:0001730) | 1.88079486 |
126 | Abnormal tarsal ossification (HP:0008369) | 1.87685868 |
127 | Ureteral duplication (HP:0000073) | 1.87572226 |
128 | Myositis (HP:0100614) | 1.87087363 |
129 | Congenital sensorineural hearing impairment (HP:0008527) | 1.87024737 |
130 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.86690692 |
131 | Posterior subcapsular cataract (HP:0007787) | 1.86317062 |
132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84732858 |
133 | Osteomyelitis (HP:0002754) | 1.84008360 |
134 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.83913983 |
135 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.83611732 |
136 | Dry hair (HP:0011359) | 1.83578382 |
137 | Abnormal hair laboratory examination (HP:0003328) | 1.83307217 |
138 | Lymphoma (HP:0002665) | 1.82357558 |
139 | Progressive external ophthalmoplegia (HP:0000590) | 1.81269537 |
140 | Abnormal pancreas size (HP:0012094) | 1.81133614 |
141 | Abnormality of the renal collecting system (HP:0004742) | 1.79809921 |
142 | Restrictive lung disease (HP:0002091) | 1.78755006 |
143 | Ureteral stenosis (HP:0000071) | 1.78564903 |
144 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77041085 |
145 | Abnormal ciliary motility (HP:0012262) | 1.75759741 |
146 | Hypoglycemic coma (HP:0001325) | 1.75527181 |
147 | Abnormality of the nasal mucosa (HP:0000433) | 1.74887424 |
148 | Hypochromic anemia (HP:0001931) | 1.74835219 |
149 | Stomatitis (HP:0010280) | 1.74436727 |
150 | Lower limb hyperreflexia (HP:0002395) | 1.74370171 |
151 | White forelock (HP:0002211) | 1.74006578 |
152 | Skin rash (HP:0000988) | 1.73850174 |
153 | Microcytic anemia (HP:0001935) | 1.73762784 |
154 | Conical tooth (HP:0000698) | 1.73559671 |
155 | Recurrent otitis media (HP:0000403) | 1.72060790 |
156 | Hyperkalemia (HP:0002153) | 1.71982016 |
157 | Intrahepatic cholestasis (HP:0001406) | 1.71220036 |
158 | Abnormality of renin-angiotensin system (HP:0000847) | 1.71033289 |
159 | Alkalosis (HP:0001948) | 1.70824140 |
160 | Duplicated collecting system (HP:0000081) | 1.70310163 |
161 | Impulsivity (HP:0100710) | 1.69789867 |
162 | Cardiovascular calcification (HP:0011915) | 1.69205736 |
163 | Xerostomia (HP:0000217) | 1.69008839 |
164 | Encephalitis (HP:0002383) | 1.68952229 |
165 | Oligodontia (HP:0000677) | 1.67585133 |
166 | Abnormality of vitamin metabolism (HP:0100508) | 1.67172438 |
167 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.66961955 |
168 | Esophageal varix (HP:0002040) | 1.66800801 |
169 | Popliteal pterygium (HP:0009756) | 1.65974714 |
170 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.65916042 |
171 | Anhidrosis (HP:0000970) | 1.65570746 |
172 | Meningitis (HP:0001287) | 1.65000909 |
173 | Hypophosphatemic rickets (HP:0004912) | 1.64972340 |
174 | Vacuolated lymphocytes (HP:0001922) | 1.64878539 |
175 | Abnormality of the right ventricle (HP:0001707) | 1.64186733 |
176 | Natal tooth (HP:0000695) | 1.64113382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.73612045 |
2 | MAP3K10 | 4.63156715 |
3 | EPHA2 | 4.37099105 |
4 | MST4 | 3.99086425 |
5 | BLK | 3.84416028 |
6 | SMG1 | 3.21722935 |
7 | EPHB1 | 2.98421133 |
8 | PRPF4B | 2.98215527 |
9 | FGR | 2.92500742 |
10 | FRK | 2.88298568 |
11 | AKT3 | 2.73295081 |
12 | ACVR1B | 2.69291875 |
13 | RIPK1 | 2.62366733 |
14 | CSK | 2.62123105 |
15 | IRAK4 | 2.42098132 |
16 | MAP3K13 | 2.40492954 |
17 | TRPM7 | 2.28712705 |
18 | CASK | 2.26186873 |
19 | EEF2K | 2.25544629 |
20 | ERN1 | 2.12035678 |
21 | STK10 | 1.96452816 |
22 | TAOK3 | 1.81490755 |
23 | YES1 | 1.81294389 |
24 | PTK2 | 1.80023041 |
25 | TAF1 | 1.79469232 |
26 | EIF2AK3 | 1.73726658 |
27 | BCR | 1.68837835 |
28 | LATS1 | 1.67951746 |
29 | MAP3K14 | 1.63780895 |
30 | TYK2 | 1.62199633 |
31 | PRKG2 | 1.61754289 |
32 | MST1R | 1.56386250 |
33 | MAP3K9 | 1.54773373 |
34 | MAP3K12 | 1.52723297 |
35 | TEC | 1.50549122 |
36 | SIK3 | 1.49343174 |
37 | CSF1R | 1.49225844 |
38 | ERBB3 | 1.48916211 |
39 | TLK1 | 1.39806226 |
40 | ZAK | 1.38997253 |
41 | IKBKB | 1.38380123 |
42 | IKBKE | 1.37383057 |
43 | PASK | 1.28847965 |
44 | BTK | 1.28430359 |
45 | STK24 | 1.26821811 |
46 | PTK6 | 1.22880397 |
47 | GRK6 | 1.21239229 |
48 | FER | 1.21236313 |
49 | CDK9 | 1.14241751 |
50 | SYK | 1.11522754 |
51 | CDK12 | 1.07378909 |
52 | FGFR4 | 1.05402394 |
53 | EPHA3 | 1.02749130 |
54 | MAP2K2 | 1.02606147 |
55 | STK39 | 1.02516072 |
56 | ITK | 1.01585695 |
57 | CHUK | 1.01207568 |
58 | NUAK1 | 1.00753186 |
59 | TBK1 | 0.99343699 |
60 | MATK | 0.98234387 |
61 | MAP2K6 | 0.98065943 |
62 | CDK4 | 0.97924025 |
63 | RIPK4 | 0.97495453 |
64 | PRKCI | 0.90226356 |
65 | MAPKAPK3 | 0.89324082 |
66 | FGFR3 | 0.88654800 |
67 | MAP3K7 | 0.87328150 |
68 | MAP3K3 | 0.87264237 |
69 | MET | 0.86952672 |
70 | NEK9 | 0.86398899 |
71 | MAPKAPK2 | 0.85238908 |
72 | JAK3 | 0.83899355 |
73 | STK38L | 0.82374305 |
74 | GRK1 | 0.82161509 |
75 | PIK3CA | 0.82103174 |
76 | ICK | 0.81269658 |
77 | PAK4 | 0.81175744 |
78 | TRIB3 | 0.80634620 |
79 | LMTK2 | 0.80090271 |
80 | BRSK2 | 0.75901491 |
81 | IRAK2 | 0.74605436 |
82 | LRRK2 | 0.71808736 |
83 | PDK1 | 0.70782420 |
84 | ADRBK2 | 0.70507448 |
85 | MAPK15 | 0.70271028 |
86 | BUB1 | 0.69345601 |
87 | SRPK1 | 0.68686388 |
88 | LYN | 0.68613229 |
89 | CDC42BPA | 0.67775503 |
90 | NLK | 0.66977672 |
91 | MAP3K8 | 0.66481676 |
92 | HIPK2 | 0.66361917 |
93 | CDK8 | 0.65387568 |
94 | JAK1 | 0.63725825 |
95 | VRK2 | 0.62317908 |
96 | SIK1 | 0.62308685 |
97 | TTK | 0.61740595 |
98 | STK11 | 0.61530642 |
99 | SIK2 | 0.57455419 |
100 | VRK1 | 0.55355261 |
101 | HCK | 0.54815676 |
102 | MAP3K11 | 0.53979246 |
103 | PDPK1 | 0.52983619 |
104 | MARK3 | 0.52571676 |
105 | CSNK1A1L | 0.52558514 |
106 | STK3 | 0.52396336 |
107 | WNK4 | 0.50383552 |
108 | DMPK | 0.48843748 |
109 | MELK | 0.48478714 |
110 | BRAF | 0.48446092 |
111 | RPS6KB1 | 0.45813591 |
112 | WNK1 | 0.45484698 |
113 | TGFBR2 | 0.45417954 |
114 | PIM2 | 0.45249583 |
115 | TTN | 0.44773452 |
116 | IRAK3 | 0.44647999 |
117 | RPS6KB2 | 0.43300975 |
118 | PINK1 | 0.40869402 |
119 | CDC7 | 0.39377205 |
120 | MYLK | 0.39352566 |
121 | FYN | 0.38826519 |
122 | MAP3K1 | 0.38102973 |
123 | PRKCQ | 0.37935079 |
124 | BMPR2 | 0.37901092 |
125 | MAPK7 | 0.37830073 |
126 | ATR | 0.37238271 |
127 | MAP3K2 | 0.36838104 |
128 | CHEK1 | 0.36568899 |
129 | EIF2AK2 | 0.36409008 |
130 | SGK3 | 0.36274099 |
131 | LCK | 0.35706869 |
132 | CAMK1D | 0.35436338 |
133 | IRAK1 | 0.35194718 |
134 | TNK2 | 0.34288424 |
135 | DAPK2 | 0.33591608 |
136 | ROCK2 | 0.33516418 |
137 | RPS6KA2 | 0.33436654 |
138 | GRK7 | 0.33060900 |
139 | EPHB2 | 0.32648247 |
140 | PRKCE | 0.30311986 |
141 | FGFR1 | 0.28516536 |
142 | INSR | 0.28379963 |
143 | ABL1 | 0.26972362 |
144 | BMX | 0.26784276 |
145 | ADRBK1 | 0.26711244 |
146 | RPS6KA1 | 0.25914040 |
147 | GSK3A | 0.25906825 |
148 | PIM1 | 0.25901853 |
149 | PRKAA2 | 0.25543213 |
150 | MAPK11 | 0.25461583 |
151 | EGFR | 0.25053355 |
152 | MAPK12 | 0.25012387 |
153 | SRC | 0.24550228 |
154 | OXSR1 | 0.24197545 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.49589003 |
2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.25316437 |
3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.82840529 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.64815064 |
5 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.60473101 |
6 | Mineral absorption_Homo sapiens_hsa04978 | 2.48175596 |
7 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.24886449 |
8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.10863910 |
9 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.99647987 |
10 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98398377 |
11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.89122629 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88698633 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.88152384 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85496867 |
15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72994066 |
16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72342549 |
17 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.70909152 |
18 | Adherens junction_Homo sapiens_hsa04520 | 1.70576074 |
19 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.65524077 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57671737 |
21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56654893 |
22 | Bladder cancer_Homo sapiens_hsa05219 | 1.54385552 |
23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53721528 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39482905 |
25 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38220740 |
26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37228327 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36778756 |
28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34105873 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30873977 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29167786 |
31 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26823322 |
32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.26731686 |
33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26326273 |
34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.26028570 |
35 | Shigellosis_Homo sapiens_hsa05131 | 1.25184736 |
36 | Tight junction_Homo sapiens_hsa04530 | 1.21362360 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14192256 |
38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13733109 |
39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.13715769 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13653736 |
41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09368526 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.06916221 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06384890 |
44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04282800 |
45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03355743 |
46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.03189741 |
47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02727288 |
48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02441518 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00489509 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 1.00151505 |
51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99961816 |
52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99174368 |
53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96231148 |
54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95147646 |
55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94837034 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 0.94645601 |
57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94412156 |
58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94123023 |
59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93717848 |
60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93680185 |
61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.93034587 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92908829 |
63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92829336 |
64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92195576 |
65 | Taste transduction_Homo sapiens_hsa04742 | 0.89711604 |
66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87866157 |
67 | Phagosome_Homo sapiens_hsa04145 | 0.87429960 |
68 | Pathways in cancer_Homo sapiens_hsa05200 | 0.86591957 |
69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85590344 |
70 | Melanoma_Homo sapiens_hsa05218 | 0.85347573 |
71 | Measles_Homo sapiens_hsa05162 | 0.85116187 |
72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84976498 |
73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.84948454 |
74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84264756 |
75 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83394645 |
76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83160777 |
77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82594961 |
78 | Pertussis_Homo sapiens_hsa05133 | 0.81431747 |
79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80074302 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80008540 |
81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79812681 |
82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79429599 |
83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78839218 |
84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78255041 |
85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77665494 |
86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77635433 |
87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77024769 |
88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76305478 |
89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75783868 |
90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75341566 |
91 | Apoptosis_Homo sapiens_hsa04210 | 0.73233556 |
92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.73154635 |
93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72356005 |
94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72299825 |
95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72285092 |
96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71515175 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70540524 |
98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70527910 |
99 | Axon guidance_Homo sapiens_hsa04360 | 0.69910135 |
100 | Amoebiasis_Homo sapiens_hsa05146 | 0.69674765 |
101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69517254 |
102 | Focal adhesion_Homo sapiens_hsa04510 | 0.69340000 |
103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68920898 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.68240768 |
105 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67945400 |
106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67714071 |
107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66396477 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66357765 |
109 | Asthma_Homo sapiens_hsa05310 | 0.65916894 |
110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65248108 |
111 | Insulin resistance_Homo sapiens_hsa04931 | 0.64688425 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64113933 |
113 | DNA replication_Homo sapiens_hsa03030 | 0.64074933 |
114 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63659714 |
115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63172526 |
116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60403431 |
117 | Homologous recombination_Homo sapiens_hsa03440 | 0.60192175 |
118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59009328 |
119 | Legionellosis_Homo sapiens_hsa05134 | 0.57616339 |
120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57079880 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56826941 |
122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56610719 |
123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56258451 |
124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55827814 |
125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55673304 |
126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55456196 |
127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55430960 |
128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55381737 |
129 | Hepatitis B_Homo sapiens_hsa05161 | 0.54945522 |
130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54640042 |
131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54175857 |
132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53913197 |
133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53830862 |
134 | Bile secretion_Homo sapiens_hsa04976 | 0.53745721 |
135 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53694584 |
136 | ABC transporters_Homo sapiens_hsa02010 | 0.52813535 |
137 | Peroxisome_Homo sapiens_hsa04146 | 0.52360618 |
138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52328803 |
139 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51954028 |
140 | RNA degradation_Homo sapiens_hsa03018 | 0.51879833 |
141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51719355 |
142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51287342 |
143 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50829262 |
144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50714331 |
145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50633016 |
146 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50542833 |
147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50219672 |
148 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48185077 |
149 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46850914 |
150 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46387047 |
151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46374132 |
152 | Base excision repair_Homo sapiens_hsa03410 | 0.45163227 |
153 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43261440 |
154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42313572 |
155 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41874011 |
156 | Mismatch repair_Homo sapiens_hsa03430 | 0.38765839 |
157 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32868950 |